Maggot Debridement Market Size Worth $19.7 Million By 2027 | CAGR: 9.7%

The global maggot debridement market size is expected to reach USD 19.7 million by 2027 according to a new study by Polaris Market Research. The report “Maggot debridement Market Share, Size, Trends, Industry Analysis Report, By Administration Type (Biobags, Loose Larva); By End Use (Hospital, Wound Care Centers, Clinics & Others); By Application; By Regions; Segment Forecast, 2020-2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Maggot debridement therapy is defined as the future technology of the wound debridement process. Researchers are constantly developing different techniques for safe, quick, and easy wound debridement therapies. Maggot therapy helps in the treatment of pressure ulcers, neuropathic foot ulcers, non-healing dead skin & soft tissue wounds, venous stasis ulcers, and post-surgical wounds.

Recent developments in maggot debridement include the usage of sterile maggots in wound debridement therapy (MDT) in South Africa, the U.S., and Europe. The recent emergence of antimicrobial resistance has updated an interest in maggot debridement therapy utilizing the larvae of lucilia sericata and for this purpose, the Inqaba Biotec and the University of Pretoria have partnered together to expand the commercial production and for the usage of sterile maggots for wound healing in South Africa.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/maggot-debridement-market/request-for-sample

The significant factors favoring the global market growth include the increasing incidents of street mishaps, surgeries, burns, trauma, and road accidents globally that are responsible for the prolonged hospitalization due to the injuries & surgeries which drive the demand for these products. Every year around 2 million people are critically injured in accidents which have led to increased demand, propelling the market growth.

A Griffith University project is investigating the usage of maggots in therapeutic medicinal purposes in compromised healthcare settings which has been granted by the Humanitarian Grand Challenge Canada. The Humanitarian Grand Challenge has also raised funds of around USD 250,000 for these project studies.

Companies such as Smith & Nephew, Monarch Labs, Coloplast, Mega Pharma (Pvt) Ltd., BioMonde, B. Braun Melsungen AG, Molnlycke Healthcare, ConvaTec, Lohmann & Rauscher, Arobella Medical, LLC Integra Lifesciences, Advancis Medical, DeRoyal Industries, RLS Global, EZ Debride & Sanara MedTech Inc. are some of the key players operating in the global market.

Players in the market are focusing on mergers & acquisitions, collaborations, product extension, and geographical expansion. Also, the companies are making huge investments in research & development activities to develop new products and to compete with the other players.

In April 2019, The RLS Global AB has announced that ChloraSolv, a wound care product, used for treating diabetic foot ulcers, has obtained a CE approval on the basis of the confirmation from Lloyd’s Register, (The Notified Body) & henceforth it is approved in 32 European countries for distribution. ChloraSolv is a Sweden based novel technology that utilizes RLS Global proprietary buffered hypochlorite technology for the debridement and cleaning of the wounds to assists in the natural wound healing process.

Polaris Market Research has segmented the maggot debridement market report based on administration type, application, end-use, and region

Maggot Debridement Administration Type Outlook (Revenue - USD Million, 2016 – 2027)

• Biobags
• Loose Larva

Maggot Debridement Application Outlook (Revenue - USD Million, 2016 – 2027)

• Acute Wounds
  • Burn Wounds
  • Surgical & Traumatic Wounds
• Chronic Wounds
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Others

Maggot Debridement End Use Outlook (Revenue - USD Million, 2016 – 2027)

• Hospital
• Wound Care Centers
• Clinics
• Others

Maggot Debridement Regional Outlook (Revenue - USD Million, 2016 – 2027)

• North America
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
• Central & South America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa